Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems

Simple item page
dc.contributor.authorSunil Shrestha
dc.contributor.authorJanuka Khatri
dc.contributor.authorS Shakya
dc.contributor.authorKrisha Danekhu
dc.contributor.authorAsmita Priyadarshini Khatiwada
dc.contributor.authorRanjit Sah
dc.contributor.authorBhuvan KC
dc.contributor.authorVibhu Paudyal
dc.contributor.authorSaval Khanal
dc.contributor.authorAlfonso J. Rodríguez‐Morales
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T13:56:51Z
dc.date.available2026-03-22T13:56:51Z
dc.date.issued2021
dc.descriptionCitaciones: 54
dc.identifier.doi10.1007/s40267-021-00852-z
dc.identifier.urihttps://doi.org/10.1007/s40267-021-00852-z
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/43651
dc.language.isoen
dc.publisherAdis, Springer Healthcare
dc.relation.ispartofDrugs & Therapy Perspectives
dc.sourceMonash University Malaysia
dc.subjectPandemic
dc.subjectMedicine
dc.subjectPharmacovigilance
dc.subjectContext (archaeology)
dc.subjectCoronavirus disease 2019 (COVID-19)
dc.subjectPublic health
dc.subjectAdverse effect
dc.subjectIntensive care medicine
dc.subjectCoronavirus
dc.subjectInfectious disease (medical specialty)
dc.titleAdverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems
dc.typearticle

Files

Collections

Artículo Científico Publicado